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Nutraceutical compounds as plant flavonoids play an important role in prevention and
modulation of diverse heath conditions, as they exert interesting antifungal, antibacterial,
antioxidant, and antitumor effects. They also possess anti-inflammatory activities in
arthritis, cardiovascular disease or neurological diseases, as well as modulatory effects
on the CYP450 activity on diverse drugs. Most flavonoids are bioactive molecules of
plant origin, but their industrial production is sometimes hindered due to reasons as
low concentration in the plant tissues, presence in only some species or as a complex
mixture or inactive glycosides in plant vacuolae. In this work, we describe the de novo
biosynthesis of two important flavones, apigenin and luteolin, and one known flavanone,
eriodictyol. Their plant biosynthetic pathways have been reconstructed for heterologous
expression in Streptomyces albus, an actinomycete bacterium manageable at industrial
production level. Also, production levels for apigenin have been improved by feeding
with naringenin precursor, and timing for settlement of secondary metabolism has been
advanced by spore conditioning. In the cases of eriodictyol and luteolin, their production
in this important type of biotechnology-prone bacteria, the actinomycetes, had not been
described in the literature yet.
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INTRODUCTION
Polyphenols are one of the largest and widely natural products distributed in plant cells, since more
than 10,000 phenolic compounds have been described so far in higher plants, with several 100
found in edible plants (Manach et al., 2004; Tsao, 2010; Li et al., 2014). Flavonoids (Latin flavus,
“yellow”) represent 60% of these polyphenols and cover more than 6000 compounds ubiquitously
distributed in plants (Chaudhuri et al., 2013; González-Vallinas et al., 2013).
All flavonoids have a generic chemical structure consisting of 15 carbon atoms (C6-C3-C6): two
aromatic rings (rings A and B) connected by a heterocyclic pyran C which contains one oxygen
(ring C, Figure 1) (Kumar and Pandey, 2007; Verma and Pratap, 2010; Liu, 2013; Ravishankar et al.,
2013; Fantini et al., 2015). This basic skeleton can have multiple substituents, as hydroxyl groups as
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FIGURE 1 | (A) Biosynthetic pathway for biosynthesis of the flavones apigenin and luteolin and the flavanone eriodictyol in plants (using PAL and C4H) and in
Streptomyces albus (suing TAL). (B) Recombinant plasmids constructed in this work for the heterologous biosynthesis of these flavonoids.
well as sugars (Crozier et al., 2009). Depending on the pattern
of hydroxylation and the substituents on the heterocyclic ring
C, flavonoids can be classified into several sub-groups, but in
this paper we focus on two groups: flavones as luteolin (present
in Thai chili, broccoli and leaves of onion and celery) and
apigenin (present in parsley, celery, onion, garlic, red pepper, and
chamomile tea); and flavanones (as eriodictyol found in citrus
fruits such as orange, lemon, or grapefruit) (Manach et al., 2004;
Tsao, 2010; Liu, 2013).
The biological activities of these compounds depend
both on their structural differences and glycosylation
patterns (Kumar and Pandey, 2007; Tsao, 2010). In fact,
diet flavonoids can promote health and prevent certain diseases
such as cancer by acting against cell oxidation processes
and by stopping cell degradation and aging (Luo et al.,
2015).
The effects of flavonoids in humans can be attributed
to antioxidant, antitumor, anti-inflammatory, antimicrobial,
anticancer, and cardiovascular actions. For example, eriodictyol
performs a key role against the pathogenesis of diabetes
mellitus, inhibiting immunoglobulin E/antigen-produced type
I hypersensitivity. This flavanone also shows antinociceptive,
hyperthermic, and anticancer effects (Zhu L. et al., 2014).
Apigenin has a growing importance due to its inhibitory
effect on the PI3K/Akt/mTOR signaling pathways (Tong and
Pelling, 2013). Luteolin is able to inhibit angiogenesis or
to reduce tumor size in vivo since it is able to modulate
protein kinases and growth factor receptors as EGFRs or
VEGFRs (López-Lázaro, 2006). Also, the antioxidant capacity of
these and other polyphenols acts as master key in preventing
numerous diseases associated with oxidative damage such as
cardiovascular, neurodegenerative and cancer (Ravishankar et al.,
2013; Hollman, 2014).
Flavonoids are synthesized in planta by the phenylpropanoid
pathway, which converts L-Phe in 4-coumaroyl-CoA in
three steps, the common intermediate for all flavonoids
(Figure 1) (Falcone Ferreyra et al., 2012). These first three
common steps are catalyzed by phenylalanine ammonia lyase
(PAL), cinnamate 4-hydroxylase (4CH) and 4-coumaroyl
CoA ligase (4CL) (Figure 1). Then the chalcone synthase
(CHS) condenses a molecule of 4-coumaroyl-CoA with
three molecules of malonyl-CoA, generating naringenin
chalcone, the basic skeleton for all flavonoids (Tsao, 2010; Wang
et al., 2011; Falcone Ferreyra et al., 2012). The heterocycle
C closure is catalyzed by chalcone isomerase (CHI), which
generates naringenin, the precursor for apigenin and luteolin
(flavones) and for eriodictyol (flavanone). In order to generate
apigenin, the flavone synthase (FNS) oxidoreductase is required.
Apigenin is then the substrate for the flavonoid 3′-hydroxylase
(F3′H), giving rise to luteolin (Figure 1). On the other
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hand, naringenin is also the substrate for F3′H, generating
eriodictyol without FNS activity (Figure 1) (Crozier et al.,
2009).
Flavonoids are valuable compounds for use in the
pharmaceutical, chemical and nutraceutical industry, but
the amounts that can be obtained directly from plants
are very limited. One solution is the chemical synthesis,
but when dealing with metabolites with complex chemical
structures, their production is economically not feasible
in most cases. Therefore, an attractive alternative is to
express these plant biosynthetic gene pathways in microbial
factories, using combinatorial biosynthesis, where genes
from different organisms are grouped in an artificial gene
cluster directed to the production of the natural bioactive
compound (Falcone Ferreyra et al., 2012; Trantas et al.,
2015). Microorganisms that are most commonly used as
cell factories for flavonoids are Saccharomyces cerevisiae,
Escherichia coli and in some cases Streptomyces venezuelae, where
different techniques are applied in order to increase production
levels.
However, in the last years, focus has been made in de novo
processes for flavonoids microbial production, without adding
expensive precursors to the culture medium, therefore allowing
cheap production platforms necessary for broad commercial
use of flavonoids as nutraceuticals (Fowler and Koffas, 2009;
Wang et al., 2011; Wu et al., 2014). In this work, we have
achieved de novo production of apigenin, luteolin, and eriodictyol
by means of synthetic biosynthetic pathways heterologous
expressed in Streptomyces albus. The use of Gram-positive
bacterial factories, as this actinomycete, facilitates the further
industrialization of bioactive compounds for the pharmaceutical
industry, as on the one hand, actinomycetes are the most diverse
and rich producers of bioactive compounds (antibacterials,
antifungals, antitumors, herbicides, immunosuppressors, etc.),
belonging to many different biochemical families (lactams,
polyketides, non-ribosomal peptides, terpenoids, flavonoids,
etc.), and providing all the necessary metabolic precursors
and biosynthetic machinery for these purposes, including
also all post-translationally modification enzymes (Newman
and Cragg, 2007). Actually, about two thirds of all known
bioactive polyketides are produced by actinomycetes. This
huge biosynthetic capability is accompanied also by a huge
diversity in resistance mechanisms to allow production of such
a wide range of bioactive compounds (Zhang et al., 2008;
Hwang et al., 2014). This role as useful bacterial factories
for bioactives is reinforced in the case of some actinomycetes
as Saccharopolyspora erythraea, S. coelicolor, S. lividans, S.
avermitilis, S. venezuelae and S. albus, as their genomes have
been sequenced and multiple genetic manipulation tools are
available for them. Specifically, in the case of S. albus, this
host is more convenient as it shows a fast and nice disperse
mycelial growth, instead of the most common mycelial dense
aggregates shown in the case of other actinomycetes. This
disperse growth facilitates scaling-up at industrial bioreactors,
as less complications arise from local cellular density and
cell lysis. Also, S. albus can be transformed with methylated
plasmid DNA, in contrast to other actinomycetes, which also
facilitates genetic engineering in this species (Kieser et al.,
2000).
MATERIALS AND METHODS
Bacterial Strains, Plasmids, and Culture
Conditions
Escherichia coli TOP10 (Invitrogen) and pUC57 (Fermentas)
were used for routine sub-cloning. The high-copy number
shuttle vector pIAGO (Table 1) for E. coli–Streptomyces,
which contains the strong constitutive ermE promoter PermE∗
(Aguirrezabalaga et al., 2000), was used as expression plasmid
in the strain S. albus J1074 (Chater and Wilde, 1980), which
was used as host for the production of flavones and flavanones
(Table 2).
Escherichia coli was grown at 37◦C in TSB liquid broth or TSB
agar (VWR), supplemented with the corresponding antibiotics
for plasmid selection (ampicillin 100 µg/ml, Sigma Aldrich).
S. albus J1074 was grown at 30◦C in YEME 17% sucrose (Kieser
et al., 2000) for the preparation of protoplasts. It was sporulated
on Bennet medium (Kieser et al., 2000), and supplemented
with the corresponding antibiotics when necessary (thiostrepton
50 µg/ml, Sigma Aldrich).
For flavonoids production, S. albus clones were grown in 25 ml
of R5A medium (Fernández et al., 1998), supplemented with
the corresponding antibiotic, during 184 h (96 h for feeding
TABLE 1 | List of plasmids used in this study.
Plasmid Description Source
pIAGO pWHM3 (replicative shuttle vector)
harboring permE∗
Aguirrezabalaga
et al., 2000
pSL1180 E. coli vector Brosius, 1989
pUC57 E. coli vector Fermentas
pLMF1 pUC57 harboring TAL This study
pLMF2 pUC57 harboring 4CL This study
pLMF3 pUC57 harboring CHS This study
pLMF5 pUC57 harboring CHI This study
pLMF-FNS pUC57 harboring FNS This study
pLMF7 pSL1180 harboring TAL This study
pLMF8 pSL1180 harboring TAL and 4CL This study
pNGM1 pSL1180 harboring CHS and FNS This study
pNGM2 pSL1180 harboring TAL, 4CL, CHS, and
FNS
This study
pNGM3 pSL1180 harboring TAL, 4CL, CHS, FNS,
and CHI
This study
pAPI pIAGO harboring TAL, 4CL, CHS, FNS, and
CHI
This study
pNGM4 pSL1180 harboring TAL, 4CL, CHS, F3′H,
and CHI
This study
pERI pIAGO harboring TAL, 4CL, CHS, F3′H,
and CHI
This study
pNGM5 pSL1180 harboring TAL, 4CL, CHS, FNS,
CHI, and F3′H
This study
pLUT pIAGO harboring TAL, 4CL, CHS, FNS,
CHI, and F3′H
This study
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TABLE 2 | List of strains used in this study.
Strains Description Source
E. coli TOP10 Strain used for routine sub-cloning
and transformation in S. albus
Invitrogen
Streptomyces albus
J1074
Strain used to create the
flavonoid-producing mutants
Chater and
Wilde, 1980
S. albus-pIAGO S. albus harboring pIAGO used as
negative control
This study
S. albus-pAPI S. albus harboring pAPI This study
S. albus-pERI S. albus harboring pERI This study
S. albus-pLUT S. albus harboring pLUT This study
experiments) at 30◦C and at 250 rpm. Spores were previously
quantified and an inoculum of 107 spores/ml was used always as
inoculum.
DNA Manipulation
Restriction enzymes were purchased from Takara Biochemicals,
T4 DNA ligase, Klenow fragment and Dream Taq DNA
Polymerase from Thermo Scientific. Synthetic genes for
the following ORFs (EBI preliminary accession number
Hx2000056376) were generated by Genecust after codon
optimization: TAL (as BglII-PstI gene cassette) from Rhodobacter
capsulatus (GenBank accession no. WP_013066811), 4CL (as
PstI-SacI gene cassette) from S. coelicolor (GenBank accession
no. NP_628552), CHS (as SacI-EcoRI gene cassette) from Glycine
max (GenBank accession no. L07647.1), CHI (as XbaI-EcoRV
gene cassette) from G.max (GenBank accession no. AY595413.1),
FNS (as EcoRI-XbaI gene cassette) from Petroselinum crispum
(GenBank accession no. AY230247.1) and F3′H (as EcoRV-
BamHI gene cassette) from Arabidopsis thaliana (GenBank
accession no. Q9SD85). Compatible restriction sites were added
at each gene cassette end, in order to facilitate construction of
the recombinant flavonoids gene clusters, as well as ribosome
binding sites at the 5′-ends.
All constructed plasmids (Figure 1) described below were
verified by restriction enzymes digestions and also by sequencing
of the cloned regions. S. albus producing clones were confirmed
by PCR by the use of oligonucleotides designed to amplify
the junction site at the first two common genes (TAL and
4CL): 5′-GTGATCGAGCTGGACATGAA-3′ as the forward
primer and 5′-GGCGTCCACGAGGTGC-3′ as the reverse
primer.
Construction of pAPI
The plasmid pAPI is a pIAGO derivative (Table 1) containing
the PermE∗ and the five genes responsible for apigenin de novo
biosynthesis. All synthetic gene cassettes were independently
cloned in pUC57 and those plasmids were named pLMF1
(pUC57 containing TAL gene), pLMF2 (4CL), pLMF3 (CHS),
pLMF5 (CHI), and pLMF-FNS (FNS). Additionally, TAL gene
was subcloned into vector pSL1180 as HindIII-BamHI (pLMF7)
to start with the cloning strategy. 4CL gene (from pLMF2) was
cloned into pLMF7 as PstI-BamHI gene cassette, generating
pLMF8. Next step was subcloning FNS gene cassette from pLMF-
FNS into pLMF3 as an EcoRI-XbaI DNA fragment, giving rise to
pNGM1. The two gene cassettes from pNGM1 (CHS and FNS)
were subcloned together into pLMF8 as SacI-BamHI DNA band,
in order to get the first four genes together in a plasmid (pNGM2).
Finally, CHI gene was subcloned into pNGM2 as XbaI-BamHI
DNA fragment resulting in the generation of pNGM3, which
contains the five genes required for apigenin biosynthesis.
As the expression host was Streptomyces, a further subcloning
was required, and the BglII-BamHI DNA fragment from pNGM3
carrying these five genes was finally subcloned into a derivative of
the bifunctional replicative vector pIAGO, under the control of
PermE∗ , giving rise to the final plasmid pAPI.
Construction of pLUT
The plasmid pLUT (Table 1) directs the biosynthesis of luteolin
and contains the six required genes (TAL, 4CL, CHS, CHI,
FNS, and F3′H), as well as the PermE∗ . This plasmid requires
only one more gene (F3′H) than those ones present in pAPI.
Therefore, pNGM3 was used for the construction of pLUT. The
gene cassette F3′H was subcloned into pNGM3 as an EcoRV-
BamHI DNA fragment. This plasmid was named pNGM5 and
contains all six genes. These genes were further subcloned as a
BglII-BamHI DNA fragment into the pIAGO vector, in order to
achieve expression in S. albus, giving rise to plasmid pLUT.
Construction of pERI
The plasmid pERI (Table 1) contains the PermE∗ and the five genes
required for the biosynthesis of eriodictyol. These genes are the
ones encoding for TAL, 4CL, CHS, CHI, and F3′H. As all the
genes but the one coding for FNS are the same ones required
to produce luteolin, the construction of the plasmid directing
the biosynthesis of eriodictyol was based on the previously
described plasmid, pNGM5. This plasmid was digested with
EcoRI-XbaI, and then blunt-ended with Klenow fragment, to
eliminate the gene cassette FNS. This new pSL1180 derivative
plasmid was named pNGM4. In order to express these five
genes in S. albus, they were subcloned in the replicative vector
pIAGO as a BglII-BamHI DNA fragment, giving rise to the final
plasmid, pERI.
Extraction and Analysis of Flavonoids
Spores from the different S. albus J1074 recombinant clones
harboring pAPI, pERI, pLUT, and pIAGO (negative control) were
incubated during 184 h in 25 ml of liquid production medium
R5A. Flavonoids extraction was carried out using three volumes
of ethyl acetate and extracting separately the supernatant and
the disrupted mycelium pellet (after acetone treatment). These
extraction mixtures were incubated for 1 h in orbital shaker at
room temperature. After this incubation, the organic phases were
filtered, mixed together and concentrated by rotary evaporation
and kept at−20◦C for later use. All cultivation experiments were
carried out three times for each strain or analysis.
Dry extracts were dissolved in 200 µl of methanol:DMSO
(1:1), filtrated (0.4 µm cellulose filters) and analyzed by liquid
chromatography-electrospray ionization mass spectrometry
(HPLC-ESI-MS/MS, Agilent technologies 1290 Infinity, Triple
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Quadrupole). This chromatography was carried out using a
Zorbax Eclipse Plus C18 column (50 mm × 2.1 mm, 1.8 µm)
in the positive ion mode. The analytes were eluted at a flow
rate of 0.3 mL/min using a gradient of 0.1% (v/v) formic acid
in water (A) and 0.1% (v/v) formic acid in acetonitrile (B) at
0–10% of B for 1 min, which was increased to 35% for 3 min and
maintained at 35% for 1 min; then increased to 80% for 3 min
and maintained at 80% for 2 min and finally decreased to 10%
for 1 min.
Flavonoids quantification was carried out in multiple reaction
monitoring (MRM) mode in MS/MS. To accomplish this, the
following ion sets were selected to detect the transitions of
the parent ions to the product ions specific to the analytes:
naringenin 272 > 119 Da and 272 > 151 Da; apigenin
270 > 117 Da and 270 > 150 Da; eriodictyol 288 > 135 Da
and 288 > 150 Da; luteolin 286 > 131 Da and 286 > 151 Da.
Pure flavonoid standards were purchased from Sigma Aldrich
(apigenin, eriodictyol, naringenin) and VWR (luteolin).
Spore Conditioning Experiments
Spore conditioning was carried out by incubating during 10 days
a suspension of 108 or 109 spores/mL in 5 mL R5A medium,
at 30◦C and 250 rpm, in 50 mL Falcon tubes (final spore
concentrations of 105 and 106 spore equivalent/mL respectively).
This incubation was carried out in order to force spore
germination in a high density culture, which induces programed
cell death in mycelium I (MI), releasing the developmental signals
that induce the differentiation (conditioning) of the MI cellular
segments that remained viable into a new mycelium (MII), that is
the secondary metabolite producer (Manteca et al., 2008). Due
to the high density, this conditioned mycelium (MII), cannot
growth too much, and remains quiescent until it is inoculated
into a fresh medium (Manteca et al., 2008).
Thirty µL of the conditioned cultures (equivalent to 3 × 106
or 3 × 107 spores) were inoculated in 25 mL R5A medium in a
250 mL buﬄed flask (triplicates). As a control, simultaneously,
other flask triplicates with 25 mL R5A medium were inoculated
with our standard conditions, 30 µL of a spore stock solution (at
1010 spores/mL), which represents a final spore concentration in
the flasks of 107 spores/mL All these nine flasks were incubated
at 30◦C and 250 rpm during 168 h, and samples were taken
every 24 h: 20 µL samples for confocal microscopy; 180 µL
samples for protein quantification using the Bradford method
(Bradford, 1976) after boiling in 0.5 M NaOH for 10 min and
after removing cellular debris by centrifugation (at 7740 × g
for 15 min); and 1.5 mL for apigenin extraction and HPLC–MS
quantification.
Feeding Experiments
Two hundred and fifty ml Erlenmeyer flasks with 25 mL R5A
medium were inoculated with 107 spores/mL of S. albus-pAPI
and incubated at 30◦C and 250 rpm during 48 h, according
with previous literature (Park et al., 2009). At this time point,
amounts of different precursors were added to achieve final
concentrations of 1.2 mM p-coumaric acid, 13.5 mM sodium
malonate, 1.2 mM p-coumaric acid plus 13.5 mM sodium
malonate, or 0.1 mM naringenin in the corresponding flasks
(triplicates). 1.5 mL of each culture was extracted at 96 h, as
described in Section “Extraction and Analysis of Flavonoids,” and
apigenin was quantified by HPLC–MS. These final precursors
concentrations were selected based in literature (Park et al., 2009,
2010).
Laser Scanning Fluorescence
Microscopy
Streptomyces albus cultures from 24 h until 96 h were
stained using the LIVE/DEAD BacLight Bacterial Viability Kit
(Invitrogen), and observed under a Leica TCS-SP2-AOBS laser
scanning microscope at wavelengths of 488 and 568 nm for
excitation and 530 and 630 nm emission (optical sections of
about 0.2 µm). Images were mixed with the Leica Confocal
Software. In these conditions, living mycelium appears green
colored (SYTO9 staining), while dying mycelium appears red (PI
staining). Septa are visible as discontinuities in the SYTO9/PI
stained hyphae; MI is fully compartmentalized, while MII (the
secondary metabolite producer mycelium) is multinucleated with
sporadic septa (Manteca et al., 2008).
RESULTS
Heterologous Production of Apigenin
The flavone apigenin is generated due to the action of the
enzyme FNS (flavone synthase) on the important flavonoid
precursor naringenina (Figure 1). In order to produce the plant
metabolite naringenin in microorganisms, four enzymes are
required: TAL, 4CL, CHS, and CHI (Figure 1). Four synthetic
genes coding for these enzymes (adapted to the transcription and
translation characteristics in prokaryotes as S. albus), together
with a synthetic gene coding for FNS, were cloned in a replicative
high-copy number shuttle vector for E. coli–Streptomyces, under
the control of PermE∗ (see Materials and Methods). The final
plasmid construction, pAPI, was transformed and successfully
expressed in the actinomycete S. albus, as a method to achieve
future industrial production of this important flavonoid.
Cultures of S. albus-pAPI in R5A liquid medium were
analyzed by HPLC–MS chromatography in MRM in MS/MS
mode, in order to identify and quantify the final product,
apigenin, as well as its intermediate precursors naringenin
and p-coumaric acid (Figure 1). p-Coumaric acid is the
second common metabolite in flavonoids biosynthesis, after
transformation of the initial aromatic amino acid precursor in
plants (L-Phe) or in microorganisms (L-Tyr) (Figure 1). The
three compounds (p-coumaric acid, naringenin, and apigenin)
were detected in these analyses and their yields were quantified
using commercial pure standards (see Materials and Methods).
Production rates for apigenin synthetized by S. albus-pAPI were
0.08 mg/L. Its precursor naringenin was produced at lower level
(0.014 mg/L), and the p-coumaric acid initial precursor for this
pathway was observed at higher concentration, reaching levels
of 0.774 mg/L (Figure 2). Negative control strain harboring the
empty vector, S. albus-pIAGO showed no flavonoids in their
HPLC–MS analyses.
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FIGURE 2 | HPLC–MS chromatograms showing the m/z peaks corresponding to naringenin (NAR), apigenin (API), luteolin (LUT), and eriodictyol (ERI).
In the corresponding S. albus strains.
Differentiation of a multinucleated mycelium (MII)
conditions secondary metabolism production (Manteca
et al., 2008). Consequently, we tested the possibility to further
improve apigenin production levels, or even anticipate time
of maximum production, as a way to save money in future
industrial fermentations, based in the improvement of the MII
differentiation. Spore conditioning experiments were carried
out with S. albus-pAPI (see Materials and Methods). Briefly,
germination in dense spore inocula force programed cell death
in the vegetative MI, releasing the developmental signals that
induce the differentiation (conditioning) of the MI cellular
segments that remained viable into a new mycelium (MII,
secondary metabolite producer). Due to the high density,
this conditioned mycelium (MII) remains quiescent until
it is inoculated into a fresh medium (Manteca et al., 2008).
Conditioning times longer that these 10 days did not show
extra advantages with respect to final effect in generation of
quiescent MII. Also, after these 10 days, the obtained mycelium
II remains quiescent and conditioned during a long time (at
least months), ready to be used in different production batches
(Manteca et al., 2008). Development and apigenin production
were compared in cultures inoculated with conditioned and non-
condtioned spores (Figures 3, 4). These experiments showed
that inocula from conditioned cultures contained high amounts
of dead mycelium pellets (red staining), non-germinated
spores, and quiescent MII (green staining) (Figure 3B). By
contrast, control cultures (non-conditioned inocula) contained
only spores (Figure 3A). After 24 h incubation, control flasks
showed normal development toward MI (Figure 3A), whereas
conditioned flasks at this point showed a high proportion of
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FIGURE 3 | Confocal laser-scanning fluorescence microscopy analysis (SYTO9/PI staining) of Streptomyces albus-pAPI development in liquid
cultures under two different conditions. (A) morphology of control cultures inoculated with a spore preinoculum. (B) Morphology of conditioned cultures
inoculated with a high-density pre-grown culture in which programed cell death processes was induced. Arrows indicate mycelium septa. MI: type I mycelium
(compartmentalized mycelium); MII: type II mycelium (multinucleated mycelium, secondary metabolite producer).
producing MII (Figure 3B). Control flasks did not show a
high proportion of MII until 72 h (Figure 3A). Accordingly,
apigenin production was faster and the maximum production
levels earlier in conditioned flasks (72 h for 106 conditioned
spore equivalent/mL flasks and 96 h for 105 conditioned spore
equivalent/mL flasks) than in the control flasks (120 h, 107
spores/mL) (Figure 4).
Finally, in order to try to increase apigenin final production
titers, feeding experiments were carried out (Figure 5). Feeding
with coumaric acid, sodium malonate or both together did not
increased significantly final apigenin titers (0.139, 0.106, and
0.159 mg/L apigenin; in contrast to 0.082 mg/L in control without
feeding). However, feeding with 0.1 mM naringenin caused a
statistically significant increase in apigenin production levels,
achieving 0.384 mg/L.
Heterologous Production of Eriodictyol
The flavanone eriodictyol is a hydroxylated form of the
flavanone precursor naringenin. For its biosynthesis, only
one extra enzymatic activity is required, the F3′H (flavonoid
3′-hydroxylase) at ring B (Figure 1), instead of the FNS
oxidoreductase. Final replacement in pAPI plasmid of the gene
cassette coding for FNS by the new one coding for F3′H generated
a vector containing the five genes (TAL, 4CL, CHS, CHI, and
F3′H) required for eriodictyol biosynthesis in S. albus under the
control of PermE∗ (see Materials and Methods).
This new recombinant plasmid, pERI, was transformed in
S. albus protoplasts, and cultures from positive recombinant
strains (in R5A liquid medium) were analyzed by MRM
chromatography. These experiments demonstrated that
recombinant plasmid pERI was able to redirect the biosynthesis
from apigenin to eriodictyol in S. albus, using as common
precursor the naringenin already detected in previous
experiments. However, production levels for eriodictyol in these
extracts were very low under these conditions (0.002 mg/L).
However, higher levels of the naringenin precursor (0.037 mg/L)
were observed. The initial precursor p-coumaric acid was also
analyzed, showing production levels of 1.256 mg/L (Figure 2).
Heterologous Production of Luteolin
Luteolin biosynthesis in microorganisms requires the activity of
six enzymes: TAL, 4CL, CHS, CHI, FNS, and F3′H. The genes
coding for these enzymes were cloned in the same replicative
high-copy number shuttle vector for E. coli–Streptomyces (see
Materials and Methods), under the control of the promoter
PermE∗ , generating the final plasmid pLUT. This plasmid was
transformed into S. albus protoplasts.
Clones of this recombinant strain were cultivated in R5A
liquid medium and flavonoids productivity was quantified
using HPLC–MS in their extracts. Luteolin was detected with
production rates of 0.09 mg/L) but its precursor apigenin was
observed at higher levels (0.085 mg/L) (Figure 2). As in previous
experiments, a higher accumulation of the initial precursor
p-coumaric acid was detected (0.872 mg/L).
DISCUSSION
In this work, S. albus has been able to de novo biosynthetize four
flavonoids: naringenin (a flavanone precursor in this family of
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FIGURE 4 | Streptomyces albus-pAPI growth curves (solid lines) and
apigenin production curves (dashed lines) for three different types of
cultivation experiments (mean values from three independent
triplicate flasks). Green colors correspond to control cultures with 107
spores/mL. Blue colors correspond to conditioned cultures with a
preinoculum of 105 spore equivalents/mL. Orange colors correspond to
conditioned cultures with a preinoculum of 106 spore equivalents/mL.
Apigenin production is anticipated in conditioned cultures, even with a
delayed growth during the first 24-h, and achieving same production levels 1
and 2 days in advance, respectively. Maximum production levels for apigenin
titers are labeled by arrows.
nutraceuticals), apigenin (its oxidized flavone derivative), luteolin
(a 3′-hydroxylated apigenin) and eriodictyol (a 3′-hydroxylated
version of the flavanone naringenin).
De novo naringenin production has been previously described
in recombinant strains of E. coli (Hwang et al., 2003; Miyahisa
et al., 2006; Santos et al., 2011), S. cerevisiae (Yan et al., 2005;
Trantas et al., 2009), and S. clavuligerus (Álvarez-Álvarez et al.,
2015). Other authors also achieved its production in other
microorganisms, but after feeding with precursors (Park et al.,
2009).
Apigenin was previously produced de novo only in E. coli
(Miyahisa et al., 2006). Here, the complete biosynthetic pathway
was cloned in E. coli and production levels reached up to 13 mg/L.
However, the addition to culture medium of the main precursor
L-tyrosine at 543 mg/L (3 mM) was required (Miyahisa et al.,
2006) (Table 3). In a more recent work, apigenin yields were
increased to 23 mg/L in E. coli. But, as in the work developed by
Miyahisa et al. (2006), its synthesis needed the supplementation
FIGURE 5 | Apigenin production titers in cultures of S. albus-pAPI
without feeding (control), and with 1.2 mM p-coumaric acid, 13.5 mM
sodium malonate, 1.2 mM p-coumaric acid plus 13.5 mM sodium
malonate, or 0.1 mM naringenin final concentrations. Only feeding with
naringenin caused a significant 468% increase in apigenin biosynthesis with
respect to control conditions. ∗Statistically significant differences (p < 0.1) by
one-way ANOVA test.
with p-coumaric acid (Lee et al., 2015). Higher production levels
in E. coli, 110 mg/L, have been described after feeding with
p-coumaric acid and malonate (Leonard et al., 2008). This flavone
was also produced in S. venezuelae at 1.5 mg/L, but only after
feeding with 0.5 mM (136 mg/L) naringenin a S. venezuelae strain
which contained only the gene coding for FNS oxidoreductase
(Park et al., 2010) (Table 3).
In this work, however, the complete biosynthetic pathway
for apigenin was heterologous expressed in S. albus. Besides, it
was not supplemented with any precursor, although the levels
of apigenin obtained (0.089 mg/L) were smaller than in other
previously described works. Only small amounts (0.001 mg/L) of
its immediate precursor naringenin were detected, indicating that
the activity of the plant oxidoreductase enzyme FNS is good in
this microorganism.
In the case of eriodictyol, according to the literature, its
biosynthesis in actinomycetes had not been described before.
However, two research groups have reported production of
this flavanone in E. coli from glucose or after feeding with
p-coumaric acid plus malonate, caffeic acid or L-tyrosine,
reaching production levels of 50, 5.70, 0.02, and 42.6 mg/L
respectively (Leonard et al., 2007, 2008; Zhu S. et al., 2014)
(Table 3). In both cases, metabolic engineering in E. coli was
carried out afterward to enhance the availability of the flavonoids
precursor malonyl-CoA, increasing the eriodictyol production
levels to 52 and 107 mg/L respectively (Leonard et al., 2007; Zhu
S. et al., 2014) (Table 3). In our case, despite the low eriodictyol
production levels in S. albus, this biosynthesis is de novo and
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TABLE 3 | List of heterologous microbial hosts for biosynthesis of flavanones and flavones in the literature and estimated production titers.
Heterologous flavonoid produced Host Externally fed precursor Production titers (mg/L) Reference
Apigenin E. coli L-Tyrosine 13 Miyahisa et al., 2006
E. coli p-Coumaric acid 23 Lee et al., 2015
S. venezuelae Naringenin 1.5 Park et al., 2010
S. venezuelae p-Coumaric acid 15.3 Park et al., 2011
S. cerevisiae p-Coumaric acid 3.5 Leonard et al., 2005
E. coli p-Coumaric acid and malonate 110 Leonard et al., 2008
Eriodictyol E. coli Caffeic acid 0.03 Leonard et al., 2006
E. coli L-Tyrosine 107 Zhu S. et al., 2014
S. cerevisiae Caffeic acid 6.5 Yan et al., 2005
S. cerevisiae Caffeic acid 20 Leonard et al., 2005
E. coli p-Coumaric acid and malonate 50 Leonard et al., 2008
Luteolin S. cerevisiae Caffeic acid 2 Leonard et al., 2005
E. coli p-Coumaric acid and malonate 4 Leonard et al., 2008
has been achieved in an actinomycete for the first time. This low
production levels, as well as the accumulation of its precursors
naringenin and p-coumaric acid, show a low activity for the
hydroxylase F3′H (see below).
In the case of the flavone luteolin, its heterologous biosynthesis
has been described in E. coli (4 mg/L) and S. cerevisiae (2 mg/L)
after feeding with p-coumaric acid plus malonate, or caffeic
acid respectively (Leonard et al., 2005, 2008) (Table 3). In our
case, we demonstrate its de novo biosynthesis in Streptomyces.
Nonetheless, as in the case of eriodictyol, luteolin yields were
low. This was expected after the observed eriodictyol results,
as luteolin biosynthesis requires also the activity of F3′H
hydroxylase (Figure 1).
These experiments showed that F3′H enzyme in S. albus is
not able to completely transform naringenin into eriodictyol
nor apigenin into luteolin. In S. albus-pLUT, no eriodictyol
was observed, indicating that the FNS enzyme is quite more
efficient than F3′H, as apigenin is detected in higher amounts
here than eriodictyol. This idea is supported also by the fact
that eriodictyol levels in S. albus-pERI were almost 300 times
lower than apigenin levels in S. albus-pAPI. Other authors have
described also that P450 hydroxylases like F3′H from eukaryotic
origin may present low solubility in prokaryotic hosts, as in this
case S. albus, because a membrane anchorage domain may not be
suitable in prokaryote systems (Park et al., 2011). The hydroxylase
F3′H is a cytochrome P450-dependent monooxygenase which
requires its integration into the membrane of the endoplasmic
reticulum of plant cells as well as the presence of a P450-reductase
carrying electrons from a donor to a NADPH P450 heme-
core complex. Functional expression of these plant membrane-
bound enzymes in microorganisms is a challenge due to several
factors, such as protein insolubility (prokaryotes do not have
endoplasmic reticulum membranes to bound) and cofactor
incorporation (Burbulis and Winkel-Shirley, 1999; Chang et al.,
2007; Fowler and Koffas, 2009). It has been shown that microbial
expression of this family of enzymes is enhanced by engineering
P450 reductases, in a way that these reductases are fused to
the corresponding P450-dependent monooxygenase, and the
membrane binding domain of these ones is deleted to increase
solubility in prokaryotic cytoplasm. Following this strategy,
soluble and functional chimeras have been obtained (Leonard
et al., 2006; Leonard and Koffas, 2007; Zhu S. et al., 2014). These
reasons for the monooxygenases counterparts could explain the
very low F3′H activity shown in this study as shown with the low
lutein and eriodictyol levels in S. albus. Therefore, these studies
in S. albus will pave the way in order to conduct further enzyme
engineering in this type of enzymes, to achieve higher production
titers (Zhu S. et al., 2014) (Table 3).
Finally, we have seen accumulation of p-coumaric acid in
our three producing strains, the second metabolite in the
pathway (after TAL activity on L-Tyr), which is common
to all flavonoid biosynthetic pathways. p-Coumaric acid is
converted to coumaroyl-CoA by the action of 4CL enzyme, which
requires malonyl CoA to synthetize the corresponding flavonoid
(naringenin chalcone in our case, Figure 1). Malonyl-CoA is
therefore a limiting factor in flavonoid production, as it is also
precursor for fatty acids biosynthesis (Winkel-Shirley, 2001). In
fact, different authors consider that this influx of malonyl-CoA is
the biggest bottleneck in the flavonoids biosynthesis, since three
molecules of malonyl-CoA are needed to generate a molecule
of eriodityol, apigenin, or luteolin in our case. Basal levels of
this metabolite inside cells are relatively low, as it is regularly
consumed during fatty acids biosynthesis, so low intracellular
malonyl-CoA availability may restrict the efficient production of
flavonoids in both E. coli and Streptomyces strains (Santos et al.,
2011; Rathnasingh et al., 2012). Accordingly, diverse described
strategies to increase flavonoids yields focused on increasing
the intracellular pool of malonyl-CoA by overexpressing the
acetyl-CoA carboxylase enzyme complex (ACC) in the host
strain (Hwang et al., 2003; Miyahisa et al., 2006; Park et al.,
2011; Wang et al., 2011). ACC overexpression increased cell
concentration malonyl-CoA in a 278% in relation to the E. coli
wild strain (Zhu S. et al., 2014). In our case, with so high
intracellular p-coumaric acid accumulation in comparison to
final flavonoids, we can hypothesize that the reason may be
also a low supply of malonyl-CoA, due to its consumption
by fatty acids biosynthesis in S. albus. However, feeding with
pure 13.5 mM sodium malonate final concentration in flasks
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did not generated a significant increase in production levels.
The cause of this may be that initially identified similar genes
in S. albus chromosome to matB (membrane malonate carrier
protein) and matC (malonyl-CoA synthetase) from S. coelicolor
counterparts (sco2443, sco2445) (Park et al., 2011), actually do
carry out other enzymatic functions in S. albus, and therefore
this bacterium cannot incorporate extracellular sodium malonate
toward flavonoids biosynthesis. As this step is the bottleneck in
flavonoids biosynthesis, addition of p-coumaric acid nor both
precursors (p-coumaric acid plus sodium malonate) does not
increase apigenin final titers (Figure 5). In order to check if
feeding with the precursor naringenin was an alternative for
increasing final apigenin levels, 0.1 mM of this flavanone were
added to S. albus-pAPI cultures, and in this case, apigenin
production levels were increased 468% (Figure 5). Once we
have achieved biosynthesis of these four flavonoids in S. albus,
future metabolic engineering in this actinomycete, where the
genome information is available, will be able to increase carbon
flux toward malonyl-CoA, most probably leading to higher
flavonoids production levels. Also, it will be possible to enhance
intracellular production levels for p-coumaric acid, or limit at
some degree possible catabolism pathways or enzymes affecting
these precursors or flavonoid intermediates.
With respect to other heterologous hosts for production of
bioactives as flavonoids, actinomycetes as S. albus, do possess the
same degree of available genetic tools for genome and metabolic
engineering, in comparison to E. coli, but more suitable and easier
genetic tools than in the case of the eukaryote S. cerevisiae, which
has the disadvantage that two copies for each gene function must
be modify. As an extra advantage, the huge genetic and metabolic
richness derived from large actinomycetes chromosomes allows
these bacteria to possess a high diversity of anabolic and catabolic
pathways in charge of providing different precursors needed
for heterologous biosynthesis of a wide fan of bioactives, as
it has been described in “Introduction” (Newman and Cragg,
2007).
With respect to the Gram-negative E. coli host, production of
nutraceuticals like flavonoids for the pharmaceutical industries
is favored in Gram-positives as S. albus. The reason for this
is that S. albus, as a canonical Gram-positive bacterium, lacks
the presence of important endotoxins for human cells, as those
derived from E. coli outer membrane. Industrial removal of these
lipopolysaccharide toxins involves costly procedures (Lopes et al.,
2010).
As an actinomycete, S. albus shows has a complex cell cycle
that can be modified in order to further increase production
yields of secondary metabolism heterologous bioactives.
Secondary metabolism is activated during the MII stage (Manteca
et al., 2008). In this work, we have carried out de novo production
of apigenin in S. albus-pAPI strain by using three alternative
cultivation approaches, with and without spore conditioning
(Manteca et al., 2008). It is noticeable that similar production
levels were obtained in conditioned and not conditioned cultures,
but production was anticipated up to 2 days in the conditioned
cultures, even with a delayed growth during the first 24-h.
Consequently, conditioned cultures can be useful to manipulate
production rates in eventual S. albus industrial fermentations,
as it was reported in other streptomycetes (Sánchez and Braña,
1996; Rioseras et al., 2014).
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